Search For "novel sirolimus eluting balloon"
MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB
Updated : 2 years, 6 months ago IST
Geneva [Switzerland], September 6: The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which i
Read More
Excellent 12-month results from SELUTION SFA trial presented at JET
Updated : 2 years, 9 months ago IST
Geneva [Switzerland], May 31: 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloo
Read More
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE
Updated : 3 years, 2 months ago IST
Geneva [Switzerland], January 11 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
Read More
First patient enrolled in Erectile Dysfunction prospective randomized stud
Updated : 3 years, 6 months ago IST
Geneva [Switzerland], September 10 (ANI/PRNewswire): An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon.
Read More
First US patient enrolled in SELUTION SLR IDE Peripheral Study
Updated : 3 years, 6 months ago IST
Geneva [Switzerland], August 24 (ANI/PRNewswire): The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approv
Read More
MedAlliance SELUTION SLR receives second FDA IDE approval
Updated : 3 years, 7 months ago IST
Geneva [Switzerland], August 10 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial
Read More
First patient enrolled in SELUTION SLR IDE BTK Study
Updated : 3 years, 9 months ago IST
Leipzig [Germany], June 8 (ANI/PRNewswire): The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, just one week after receiving IDE approval.
Read More